Concepedia

Michelle T. Ashworth

MT

4

Publications

310

Citations

4

H-Index

2014

Active since

Affiliations

University of California, San Francisco(Current)

Moffitt Cancer Center

University of Washington

Michelle T. Ashworth is an author at University of California, San Francisco specializing in oncology, radiation oncology, and medicine.

Top concepts

MedicineOncologyRadiation OncologyPathologyImmunologyDermatologyImmunotherapyCancer TherapyTumor ImmunityCancer Research

Publications per year

2014–2015

4

Publications

4

Phase I Dose-Escalation Trial of Checkpoint Kinase 1 Inhibitor MK-8776 As Monotherapy and in Combination With Gemcitabine in Patients With Advanced Solid Tumors

Adil Daud, Michelle T. Ashworth, Jonathan Strosberg et al. · Journal of Clinical Oncology · 2015 · 184 citations · Full text

Characteristics of pyrexia in BRAFV600E/K metastatic melanoma patients treated with combined dabrafenib and trametinib in a phase I/II clinical trial

Alexander M. Menzies, Michelle T. Ashworth, S. Swann et al. · Annals of Oncology · 2014 · 88 citations

Medicine, Melanoma, Pathology +4

Systemic antitumor effect and clinical response in a phase 2 trial of intratumoral electroporation of plasmid interleukin-12 in patients with advanced melanoma.

Adil Daud, Alain P. Algazi, Michelle T. Ashworth et al. · Journal of Clinical Oncology · 2014 · 27 citations

Immunology, Nk Cells, Immunoediting +18

Intratumoral electroporation of plasmid interleukin-12: efficacy and biomarker analyses from a phase 2 study in melanoma (OMS-I100)

Adil Daud, Alain P. Algazi, Michelle T. Ashworth et al. · Journal of Translational Medicine · 2015 · 11 citations · Full text

Rows per page

1–4 of 4